Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in INTELLIA THERAPEUTICS INC
BNP PARIBAS FINANCIAL MARKETS holds 579,430 shares of NTLA (INTELLIA THERAPEUTICS INC), worth $7.4M as of 2026-Q1. The position was decreased (-2.0% shares). NTLA represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$7.4M
Current Shares
579,430
Total Value Change
+$4.5M
Total Shares Change
+448,419
Other major holders of NTLA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 579,430 |
-2.0% |
| $7.4M |
| 0.0% |
| $13.60 |
0 |
| 2025-Q4 | Increased | 591,277 | +1076.7% | $5.3M | 0.0% | $9.06 | 44 |
| 2025-Q3 | Decreased | 50,251 | -88.2% | $867,835 | 0.0% | $16.92 | 0 |
| 2025-Q2 | Increased | 426,667 | +25.3% | $4M | 0.0% | $9.56 | 33 |
| 2025-Q1 | Decreased | 340,457 | -22.4% | $2.4M | 0.0% | $8.07 | 0 |
| 2024-Q4 | Increased | 438,458 | +78.0% | $5.1M | 0.0% | $11.41 | 41 |
| 2024-Q3 | Increased | 246,362 | +88.0% | $5.1M | 0.0% | $21.00 | 42 |
| 2024-Q2 | Increased | 131,011 | +75.8% | $2.9M | 0.0% | $22.38 | 40 |